Cash Flow Statement

Daily Values

Growth Metrics

Income Statement

Consolidated Net Income Cost of Revenue EBIT EBITDA EBT EPS (Basic)Gross Profit Income from Continuing Operations Income towards Parent Company Net Income towards Common Stockholders Operating Expenses Operating Income Profit After Tax Research & Development Revenue Selling, General & Administrative Shares Outstanding (Weighted Average)

Others

BioLineRx (BLRX) EPS (Weighted Average and Diluted): 2012-2014

Historic EPS (Weighted Average and Diluted) for BioLineRx (BLRX) over the last 3 years, with Dec 2014 value amounting to -$0.03.